Christoph Thomssen
- Oncology top 0.2%
- Cancer Research top 0.1%
- Molecular Biology top 5%
- Pulmonary and Respiratory Medicine top 2%
- Pathology and Forensic Medicine top 1%
- Co-authors
- Nadia HarbeckManfred SchmittF. JänickeMichael GnantMichael UntchH. GraeffRudolf WankGϋnter von Minckwitz
- Topics
- Breast Cancer Treatment Studies (136 papers)Cancer Treatment and Pharmacology (83 papers)HER2/EGFR in Cancer Research (66 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Christoph Thomssen
265 papers receiving 8.3k citations
Peers
Comparison fields: 5 of 129
- Oncology 4.9k
- Cancer Research 4.5k
- Molecular Biology 2.2k
- Pulmonary and Respiratory Medicine 1.2k
- Pathology and Forensic Medicine 944
Countries citing papers authored by Christoph Thomssen
This map shows the geographic impact of Christoph Thomssen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Thomssen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Thomssen more than expected).
Fields of papers citing papers by Christoph Thomssen
This network shows the impact of papers produced by Christoph Thomssen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Thomssen. The network helps show where Christoph Thomssen may publish in the future.
Co-authorship network of co-authors of Christoph Thomssen
This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Thomssen. A scholar is included among the top collaborators of Christoph Thomssen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Thomssen. Christoph Thomssen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 8 | |
| 5 | 3 | |
| 6 | 26 | |
| 7 | 34 | |
| 8 | 35 | |
| 9 | 44 | |
| 10 | 126 | |
| 11 | 141 | |
| 12 | 50 | |
| 13 | 220 | |
| 14 | 55 | |
| 15 | 27 | |
| 16 | 93 | |
| 17 | 55 | |
| 18 | Anthracycline and trastuzumab in breast cancer treatment. | 6 |
| 19 | 25 | |
| 20 | 0 |
About Christoph Thomssen
Christoph Thomssen is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 281 papers that have together received 8.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (136 papers), Cancer Treatment and Pharmacology (83 papers) and HER2/EGFR in Cancer Research (66 papers). The work is most often cited by research in Cancer Research (4.5k citations), Oncology (4.9k citations) and Immunology and Allergy (467 citations). Christoph Thomssen has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Nadia Harbeck, Manfred Schmitt, F. Jänicke, Michael Gnant, Michael Untch, H. Graeff, Rudolf Wank, Gϋnter von Minckwitz, Sibylle Loibl and Heinz Höfler. Their work appears in journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.